Alina Potorac

Dr. Alina Potorac


Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
20 August 2025 in Life
Verified
Journal Article
Open access
PDF file
PGPariza George
Pariza George
CMCarmen Mavrodin
Carmen Mavrodin
APAlina Potorac
Alina Potorac
OMOctavian Munteanu
Octavian Munteanu
MCMonica Mihaela Cîrstoiu
Monica Mihaela Cîrstoiu
Objective: The objective of this paper is to define “poor candidates” and to conduct an analysis of preoperative selection criteria, considering factors related to the patient, tumor burden, and histopathological characteristics, in the case of patients with advanced epithelial ovarian cancer (EOC) FIGO III-IV with a low probability of optimal cytoreduction. Methodology: The authors of this narrative review conducted an analysis of articles published over a 20-year period (2005–2025), with the following selection criteria for the topics of the papers: advanced epithelial ovarian cancer (FIGOIII-IV), surgical indications in advanced ovarian cancer, poor candidates for surgery, and dependence between surgery and histopathologic and molecular type of EOC. They used using PubMed, Science Direct, and Scopus as databases. The results of the analysis were organized into three large chapters that grouped patient-related factors, tumor burden-specific factors, and histopathological criteria. Results: The authors identify a series of criteria with a high risk of unfavorable postoperative evolution, which led to delayed chemotherapy treatment and suboptimal management. These criteria are related to the patient’s field (ECOG > 3, Charlson Comorbidity Index (CCI) > 2, BMI > 25–30, hypoalbuminemia, hypokalemia), imaging or intraoperative factors predictive for residual tumor, and histopathological or genetic factors (presence of BRCA mutation favors optimal cytoreduction even in cases with high tumor burden; in the case of low-grade serous ovarian carcinoma, surgical intervention is recommended even if there are suboptimal resection criteria, accepting resection > 1 cm due to the poor response to specific chemotherapy treatment). Conclusions: Considering all these aspects, patient selection for primary debulking surgery (PDS) or NACT (neoadjuvant chemotherapy) and interval debulking surgery (IDS) should be conducted in oncological surgery centers highly specialized in gynecological neoplasms, thus ensuring an optimal therapeutic pathway for patients with EOC.

1 January 2025 in Ginecologia.ro
Verified
Journal Article
Closed access
APAlina Potorac
Alina Potorac
ANAlice Negru
Alice Negru
MCMonica-Mihaela Cîrstoiu
Monica-Mihaela Cîrstoiu
Uterine torsion is a rare and difficult condition that is most commonly encountered in pregnant women, but it can also affect non-pregnant patients. We report a case of ute­rine torsion accompanied by bilateral ovarian torsion, as­so­cia­ted with a large pedunculated subserosal fibroid, in a non-gravid patient who had previously undergone caesarean section following an in vitro fertilization (IVF) procedure. The patient complained of acute pelvic-ab­do­mi­nal pain, vomiting and lower back pain, which worsened over the course of one week. Diagnostic imaging, including contrast-en­hanced CT and ultrasound, revealed a giant cystic pelvic mass with vascularization, which initially suggested an ovarian origin. However, urgent laparotomy revealed a 25-cm fibroid with extensive necrosis and torsion. A total hysterectomy with bilateral adnexectomy was performed. The histopathological analysis confirmed a pedunculated subserosal uterine leiomyoma with ischemic necrosis and cystic transformation. Postoperatively, the patient recovered well, and she was discharged after four days. This case high­lights the importance of considering uterine torsion in the differential diagnosis of pelvic masses, particularly when associated with large fibroids.